130.05
[1]. Genovesi EV, et al. Efficacy of the carbocyclic '-deoxyguanosine nucleoside BMS-005 in the woodchuck model of hepatitis B virus infection. Antimicrob Agents Chemother. 1998 Dec;(1):309-18.
[]. Innaimo SF, et al. Identification of BMS-005 as a potent and selective inhibitor of hepatitis B virus. Antimicrob Agents Chemother. 199 Jul;1():1-9.
[3]. Rivkin A, et al. A review of entecavir in the treatment of chronic hepatitis B infection. Curr Med Res Opin. 005 Nov;1(11):185-5.
[]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 019 Feb;53():11-6.
H30-H315-H319-H335
P61-P6-P0-P1-P80-P30+P35-P30+P30-P330-P36+P36-P05-P501
GHS0